409 related articles for article (PubMed ID: 12951162)
21. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues.
González-Díaz H; Romaris F; Duardo-Sanchez A; Pérez-Montoto LG; Prado-Prado F; Patlewicz G; Ubeira FM
Curr Pharm Des; 2010; 16(24):2737-64. PubMed ID: 20642428
[TBL] [Abstract][Full Text] [Related]
22. Heme metabolism as a therapeutic target against protozoan parasites.
Lechuga GC; Pereira MCS; Bourguignon SC
J Drug Target; 2019 Aug; 27(7):767-779. PubMed ID: 30332897
[TBL] [Abstract][Full Text] [Related]
23. Molecules targeting the purine salvage pathway in Apicomplexan parasites.
Ghérardi A; Sarciron ME
Trends Parasitol; 2007 Aug; 23(8):384-9. PubMed ID: 17574921
[TBL] [Abstract][Full Text] [Related]
24. Ruthenium Metallotherapeutics: Novel Approaches to Combatting Parasitic Infections.
Britten NS; Butler JA
Curr Med Chem; 2022 Aug; 29(31):5159-5178. PubMed ID: 35366762
[TBL] [Abstract][Full Text] [Related]
25. Purine metabolism in Echinococcus multilocularis.
Suchail S; Sarciron ME; Petavy AF
Comp Biochem Physiol B Biochem Mol Biol; 1998 Aug; 120(4):633-7. PubMed ID: 9854810
[TBL] [Abstract][Full Text] [Related]
26. Development of a continuous assay for high throughput screening to identify inhibitors of the purine salvage pathway in Plasmodium falciparum.
Grube CD; Gill CP; Roy H
SLAS Discov; 2022 Mar; 27(2):114-120. PubMed ID: 35058189
[TBL] [Abstract][Full Text] [Related]
27. Novel biochemical pathways in parasitic protozoa.
Fairlamb AH
Parasitology; 1989; 99 Suppl():S93-112. PubMed ID: 2682488
[TBL] [Abstract][Full Text] [Related]
28. Resistance to antiparasitic drugs: the role of molecular diagnosis.
Sangster N; Batterham P; Chapman HD; Duraisingh M; Le Jambre L; Shirley M; Upcroft J; Upcroft P
Int J Parasitol; 2002 May; 32(5):637-53. PubMed ID: 11943235
[TBL] [Abstract][Full Text] [Related]
29. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action.
McKerrow JH
Int J Parasitol; 1999 Jun; 29(6):833-7. PubMed ID: 10480720
[TBL] [Abstract][Full Text] [Related]
30. Chitinases of human parasites and their implications as antiparasitic targets.
Shahabuddin M; Vinetz JM
EXS; 1999; 87():223-34. PubMed ID: 10906963
[TBL] [Abstract][Full Text] [Related]
31. Veterinary parasitic vaccines: pitfalls and future directions.
Vercruysse J; Knox DP; Schetters TP; Willadsen P
Trends Parasitol; 2004 Oct; 20(10):488-92. PubMed ID: 15363443
[TBL] [Abstract][Full Text] [Related]
32. Purine salvage in the apicomplexan Sarcocystis neurona, and generation of hypoxanthine-xanthine-guanine phosphoribosyltransferase-deficient clones for positive-negative selection of transgenic parasites.
Dangoudoubiyam S; Zhang Z; Howe DK
Parasitology; 2014 Sep; 141(11):1399-405. PubMed ID: 24923662
[TBL] [Abstract][Full Text] [Related]
33. Anti-parasitic Antibodies from Phage Display.
Goulart LR; da S Ribeiro V; Costa-Cruz JM
Adv Exp Med Biol; 2017; 1053():155-171. PubMed ID: 29549639
[TBL] [Abstract][Full Text] [Related]
34. Immunoendocrine host-parasite interactions during helminth infections: from the basic knowledge to its possible therapeutic applications.
Hernández-Bello R; Escobedo G; Guzmán C; Ibarra-Coronado EG; López-Griego L; Morales-Montor J
Parasite Immunol; 2010; 32(9-10):633-43. PubMed ID: 20691015
[TBL] [Abstract][Full Text] [Related]
35. Nucleoside transporters of parasitic protozoa.
Carter NS; Landfear SM; Ullman B
Trends Parasitol; 2001 Mar; 17(3):142-5. PubMed ID: 11286799
[TBL] [Abstract][Full Text] [Related]
36. Parasite Cathepsin D-Like Peptidases and Their Relevance as Therapeutic Targets.
Sojka D; Hartmann D; Bartošová-Sojková P; Dvořák J
Trends Parasitol; 2016 Sep; 32(9):708-723. PubMed ID: 27344362
[TBL] [Abstract][Full Text] [Related]
37. Structure-based drug discovery for tropical diseases.
Guido RV; Oliva G
Curr Top Med Chem; 2009; 9(9):824-43. PubMed ID: 19754397
[TBL] [Abstract][Full Text] [Related]
38. A review of the traditional use of southern African medicinal plants for the treatment of selected parasite infections affecting humans.
Cock IE; Selesho MI; Van Vuuren SF
J Ethnopharmacol; 2018 Jun; 220():250-264. PubMed ID: 29621583
[TBL] [Abstract][Full Text] [Related]
39. Vorinostat as potential antiparasitic drug.
Herrera-Martínez M; Orozco-Samperio E; Montaño S; Ariza-Ortega JA; Flores-García Y; López-Contreras L
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7412-7419. PubMed ID: 32706080
[TBL] [Abstract][Full Text] [Related]
40. microRNAs in parasites and parasite infection.
Zheng Y; Cai X; Bradley JE
RNA Biol; 2013 Mar; 10(3):371-9. PubMed ID: 23392243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
